154 related articles for article (PubMed ID: 29641740)
21. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms.
Liou MJ; Chan EC; Lin JD; Liu FH; Chao TC
Cancer Lett; 2003 Mar; 191(2):223-7. PubMed ID: 12618337
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic utility of IMP3 expression in thyroid neoplasms: a quantitative RT-PCR study.
Jin L; Seys AR; Zhang S; Erickson-Johnson MR; Roth CW; Evers BR; Oliveira AM; Lloyd RV
Diagn Mol Pathol; 2010 Jun; 19(2):63-9. PubMed ID: 20502182
[TBL] [Abstract][Full Text] [Related]
23. Carbonic anhydrase 4 and crystallin α-B immunoreactivity may distinguish benign from malignant thyroid nodules in patients with indeterminate thyroid cytology.
Davidov T; Nagar M; Kierson M; Chekmareva M; Chen C; Lu SE; Lin Y; Chernyavsky V; Potdevin L; Arumugam D; Barnard N; Trooskin S
J Surg Res; 2014 Aug; 190(2):565-74. PubMed ID: 24880201
[TBL] [Abstract][Full Text] [Related]
24. CD56 expression in benign and malignant thyroid lesions.
Muthusamy S; Azhar Sha S; Abdullah Suhaimi SN; Kassim N; Mahasin M; Mohd Saleh MF; Md Isa N
Malays J Pathol; 2018 Aug; 40(2):111-119. PubMed ID: 30173227
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
Abd-El Raouf SM; Ibrahim TR
Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
[TBL] [Abstract][Full Text] [Related]
26. Application of biomarkers in the diagnosis of uncertain samples of core needle biopsy of thyroid nodules.
Xiong Y; Li X; Liang L; Li D; Yan L; Li X; Di J; Li T
Virchows Arch; 2021 Nov; 479(5):961-974. PubMed ID: 34308507
[TBL] [Abstract][Full Text] [Related]
27. CCNA1 gene as a potential diagnostic marker in papillary thyroid cancer.
da Silva RM; Santos JN; Uno M; Chammas R; Kulcsar MAV; Sant'Anna LB; Canevari RA
Acta Histochem; 2020 Dec; 122(8):151635. PubMed ID: 33007517
[TBL] [Abstract][Full Text] [Related]
28. HBME1 and CK19 expression in non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) vs other follicular patterned thyroid lesions.
Sadiq Q; Sekhri R; Dibaba DT; Zhao Q; Agarwal S
World J Surg Oncol; 2021 May; 19(1):143. PubMed ID: 33964951
[TBL] [Abstract][Full Text] [Related]
29. Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens.
Giannini R; Faviana P; Cavinato T; Elisei R; Pacini F; Berti P; Fontanini G; Ugolini C; Camacci T; De Ieso K; Miccoli P; Pinchera A; Basolo F
Thyroid; 2003 Aug; 13(8):765-70. PubMed ID: 14558920
[TBL] [Abstract][Full Text] [Related]
30. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
31. Characterization of the novel tumor-suppressor gene CCDC67 in papillary thyroid carcinoma.
Yin DT; Xu J; Lei M; Li H; Wang Y; Liu Z; Zhou Y; Xing M
Oncotarget; 2016 Feb; 7(5):5830-41. PubMed ID: 26716505
[TBL] [Abstract][Full Text] [Related]
32. The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management.
Panebianco F; Mazzanti C; Tomei S; Aretini P; Franceschi S; Lessi F; Di Coscio G; Bevilacqua G; Marchetti I
BMC Cancer; 2015 Nov; 15():918. PubMed ID: 26581891
[TBL] [Abstract][Full Text] [Related]
33. HMGA2 Gene Expression in Fine-needle Aspiration Samples of Thyroid Nodules as a Marker for Preoperative Diagnosis of Thyroid Cancer.
Šamija I; Mateša N; Kožaj S; Majstorović I; Bolanča A; Kusić Z
Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):471-476. PubMed ID: 29406334
[TBL] [Abstract][Full Text] [Related]
34. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
[TBL] [Abstract][Full Text] [Related]
35. Utility of a multigene testing for preoperative evaluation of indeterminate thyroid nodules: A prospective blinded single center study in China.
Song Y; Xu G; Ma T; Zhu Y; Yu H; Yu W; Wei W; Wang T; Zhang B
Cancer Med; 2020 Nov; 9(22):8397-8405. PubMed ID: 32976686
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic utility of immunohistochemical panel in various thyroid pathologies.
Ozolins A; Narbuts Z; Strumfa I; Volanska G; Gardovskis J
Langenbecks Arch Surg; 2010 Sep; 395(7):885-91. PubMed ID: 20640858
[TBL] [Abstract][Full Text] [Related]
37. Expression of thyrotrophin receptor gene in thyroid carcinoma is associated with a good prognosis.
Shi Y; Zou M; Farid NR
Clin Endocrinol (Oxf); 1993 Sep; 39(3):269-74. PubMed ID: 8222289
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
[TBL] [Abstract][Full Text] [Related]
39. Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules.
Finley DJ; Arora N; Zhu B; Gallagher L; Fahey TJ
J Clin Endocrinol Metab; 2004 Jul; 89(7):3214-23. PubMed ID: 15240595
[TBL] [Abstract][Full Text] [Related]
40. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
